Olema Pharmaceuticals (OLMA) Stock Price, Quote, News & History | Benzinga

Olema Pharmaceuticals inc (OLMA) Stock Price, Quote, News & History

OLMANASDAQ

Trade with Public

Trade with Public

$10.73

-0.1-0.92%

At close: Sep 3, 5:00 PM EST

$10.73

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$10.71

Close

$10.73

Volume / Avg.

773.32K / 1.36M

Day Range

$10.58 - $10.98

52 Wk Range

5.36 - 36.26

Market Cap

$938.85M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

21.95%

Days to Cover

14.25

Recent Olema Pharmaceuticals, Inc. News

Olema Pharmaceuticals Stock Falls as Pivotal Breast Cancer Data Pushed Into 2027

Olema Pharmaceuticals shares fall after completing OPERA-01 Phase 3 enrollment, with top-line data now expected in Q1 2027.

Vandana Singh

OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

U.S. stock futures mostly lower. OppFi (OPFI) shares fall after missing Q2 earnings and cutting FY26 guidance. Other stocks also down in pre-market.

Avi Kapoor

Nvidia To Rally Around 79%? Here Are 10 Top Analyst Forecasts For Wednesday

Top analysts changed outlook on top names. Mizuho, Needham, Rothschild & Co, HC Wainwright & Co, Stifel, BTIG, Goldman Sachs made changes.

Avi Kapoor

What's Going On With Olema Pharmaceuticals Stock On Wednesday?

Olema Pharmaceuticals' stock drops after Roche breast cancer study misses key goal. Investors weigh trial results and outlook for Palazestrant.

Vandana Singh

Why Is Olema Pharmaceuticals Stock Dropping On Monday?

In November 2025, Olema Pharmaceuticals surged over 200% after Roche released phase 3 results from a lidERA Breast Cancer study.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-164.74M

Investing Cash Flow (TTM)

-99.54M

Financing Cash Flow (TTM)

260.40M

Free Cash Flow (TTM)

-164.96M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-3.87M

Analyst Trends and Forecast

6

Mar

1

May

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$491.06M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

2.20

Earnings Yield % (TTM)

-19.56%

Earnings Yield % (FWD)

-25.65%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.92

Company Debt

Total Debt

$3.00M

LT Debt

$3.00M

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-

Total Cash

$48.60M

Debt to Equity

0.01

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

-

Key Statistics

Open

$10.71

Close

$10.73

Volume / Avg.

773.32K / 1.36M

Day Range

$10.58 - $10.98

52 Wk Range

5.36 - 36.26

Market Cap

$938.85M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

21.95%

Days to Cover

14.25

About

Sector

Health Care

Industry

Biotechnology

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcom...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Olema Pharmaceuticals (OLMA) stock?

A

You can purchase shares of Olema Pharmaceuticals (NASDAQ:OLMA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Olema Pharmaceuticals (OLMA) competitors?

A

Other companies in Olema Pharmaceuticals’s space includes: Regeneron Pharmaceuticals Inc (NASDAQ:REGN), Moderna Inc (NASDAQ:MRNA), BioNTech SE (NASDAQ:BNTX), Ascendis Pharma AS (NASDAQ:ASND) and Summit Therapeutics Inc (NASDAQ:SMMT).

Q

What is the forecast, or price target, for Olema Pharmaceuticals (OLMA) stock?

A

Olema Pharmaceuticals has a consensus price target of $42.67.

Q

What is the current price for Olema Pharmaceuticals (OLMA)?

A

The stock price for Olema Pharmaceuticals (NASDAQ: OLMA) is $10.73 last updated September 3, 2026 at 4:00 PM EDT.

Q

Does Olema Pharmaceuticals (OLMA) pay a dividend?

A

There are no upcoming dividends for Olema Pharmaceuticals.

Q

When is Olema Pharmaceuticals (NASDAQ:OLMA) reporting earnings?

A

Olema Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Olema Pharmaceuticals (OLMA) going to split?

A

There is no upcoming split for Olema Pharmaceuticals.

Q

What sector and industry does Olema Pharmaceuticals (OLMA) operate in?

A

Olema Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.